Literature DB >> 20028463

Species distribution and antifungal susceptibility of blood Candida isolates at a tertiary hospital in southern Taiwan, 1999-2006.

Po-Lin Chen1, Hsiu-Jung Lo, Chi-Jung Wu, Hsin-Chun Lee, Chia-Ming Chang, Nan-Yao Lee, An-Huei Wang, Wen-Liang Lin, Nai-Ying Ko, Ching-Chi Lee, Wen-Chien Ko.   

Abstract

The aim of this study was to evaluate the incidence of candidaemia, consumption of fluconazole and susceptibility of blood Candida isolates at a tertiary hospital. From January 1999 to September 2006, all candidaemic episodes were identified and available strains were evaluated for the susceptibilities of antifungal agents. Annual defined daily doses of antifungal agents were collected. There had been 909 Candida isolates detected from the bloodstream of 843 patients during the study period. Among them, 740 isolates were available for the susceptibilities of antifungal agents. The incidence density of candidaemia was 28 episodes per 10,000 patient-days. Species distribution of 909 isolates did not vary annually, but varied greatly in the units of the hospital. Candida parapsilosis was the more prominent (30.1%) isolate in the paediatric units, where C. tropicalis and C. glabrata were less common (12.3% and 1.4% respectively). Resistance rates for itraconazole, fluconazole and voriconazole were 6.9%, 3.8% and 3.8% respectively. There were 25 (3.4%) isolates resistant to amphotericin-B. Although fluconazole usage increased over time (r(2) = 0.45; P = 0.07), fluconazole resistance did not increase accordingly (P = 0.33). In our institution in which the incidence of candidaemia was high, fluconazole resistance among blood Candida isolates remained rare.
© 2009 Blackwell Verlag GmbH.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20028463     DOI: 10.1111/j.1439-0507.2009.01818.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  7 in total

1.  Evaluating retinal toxicity of intravitreal caspofungin in the mouse eye.

Authors:  Deb K Mojumder; Francis A Concepcion; Shil K Patel; Andrew J Barkmeier; Petros E Carvounis; John H Wilson; Eric R Holz; Theodore G Wensel
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-26       Impact factor: 4.799

2.  Antifungal susceptibility and virulence attributes of bloodstream isolates of Candida from Hong Kong and Finland.

Authors:  C J Seneviratne; S S W Wong; K Y Yuen; J H Meurman; P Pärnänen; M Vaara; L P Samaranayake
Journal:  Mycopathologia       Date:  2011-07-09       Impact factor: 2.574

3.  Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012).

Authors:  Michael A Pfaller; Shawn A Messer; Ronald N Jones; Mariana Castanheira
Journal:  J Antibiot (Tokyo)       Date:  2015-04-22       Impact factor: 2.649

4.  Characterization of Candida species from different populations in Taiwan.

Authors:  Yun-Liang Yang; Li-Yun Hsieh; An-Huei Wang; Hsiu-Jung Lo
Journal:  Mycopathologia       Date:  2011-03-03       Impact factor: 2.574

5.  Loss of heterozygosity of FCY2 leading to the development of flucytosine resistance in Candida tropicalis.

Authors:  Yen-Ning Chen; Hsiu-Jung Lo; Chia-Chen Wu; Hui-Ching Ko; Te-Pin Chang; Yun-Liang Yang
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

Review 6.  Epidemiology of fungal infections in China.

Authors:  Min Chen; Yuan Xu; Nan Hong; Yali Yang; Wenzhi Lei; Lin Du; Jingjun Zhao; Xia Lei; Lin Xiong; Langqi Cai; Hui Xu; Weihua Pan; Wanqing Liao
Journal:  Front Med       Date:  2018-01-11       Impact factor: 4.592

7.  The widely used ATB FUNGUS 3 automated readings in China and its misleading high MICs of Candida spp. to azoles: challenges for developing countries' clinical microbiology labs.

Authors:  Li Zhang; He Wang; Meng Xiao; Timothy Kudinha; Lei-Li Mao; Hao-Ran Zhao; Fanrong Kong; Ying-Chun Xu
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.